Literature DB >> 22438522

When to stop a clinical trial early for benefit: lessons learned and future approaches.

Faiez Zannad1, Wendy Gattis Stough, John J V McMurray, Willem J Remme, Bertram Pitt, Jeffrey S Borer, Nancy L Geller, Stuart J Pocock.   

Abstract

Mesh：

Year:  2012        PMID： 22438522     DOI： 10.1161/CIRCHEARTFAILURE.111.965707

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  8 in total

1.  Bioethics in Practice: Considerations for Stopping a Clinical Trial Early.

Authors:  Richard E Deichmann; Marie Krousel-Wood; Joseph Breault
Journal:  Ochsner J       Date:  2016

2.  Stopping guidelines for an effectiveness trial: what should the protocol specify?

Authors:  Jon E Tyson; Claudia Pedroza; Dennis Wallace; Carl D'Angio; Edward F Bell; Abhik Das
Journal:  Trials       Date:  2016-05-10       Impact factor: 2.279

Review 3.  An Introduction to Survival Statistics: Kaplan-Meier Analysis.

Authors:  William N Dudley; Rita Wickham; Nicholas Coombs
Journal:  J Adv Pract Oncol       Date:  2016-01-01

4.  Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006-2015.

Authors:  Ileana Baldi; Corrado Lanera; Paola Berchialla; Dario Gregori
Journal:  BMJ Open       Date:  2017-06-15       Impact factor: 2.692

Review 5.  Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design.

Authors:  Gabriela J Prutsky; Juan Pablo Domecq; Patricia J Erwin; Matthias Briel; Victor M Montori; Elie A Akl; Joerg J Meerpohl; Dirk Bassler; Stefan Schandelmaier; Stephen D Walter; Qi Zhou; Pablo Alonso Coello; Lorenzo Moja; Martin Walter; Kristian Thorlund; Paul Glasziou; Regina Kunz; Ignacio Ferreira-Gonzalez; Jason Busse; Xin Sun; Annette Kristiansen; Benjamin Kasenda; Osama Qasim-Agha; Gennaro Pagano; Hector Pardo-Hernandez; Gerard Urrutia; Mohammad Hassan Murad; Gordon Guyatt
Journal:  Trials       Date:  2013-10-16       Impact factor: 2.279

6.  Advantages of Bayesian monitoring methods in deciding whether and when to stop a clinical trial: an example of a neonatal cooling trial.

Authors:  Claudia Pedroza; Jon E Tyson; Abhik Das; Abbot Laptook; Edward F Bell; Seetha Shankaran
Journal:  Trials       Date:  2016-07-22       Impact factor: 2.279

Review 7.  An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review.

Authors:  Abigail Stevely; Munyaradzi Dimairo; Susan Todd; Steven A Julious; Jonathan Nicholl; Daniel Hind; Cindy L Cooper
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

8.  Efficacy and safety of cilostazol-nimodipine combined therapy on delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a prospective, randomised, double-blinded, placebo-controlled trial protocol.

Authors:  Troy Dawley; Chad F Claus; Doris Tong; Sina Rajamand; Diana Sigler; Matthew Bahoura; Lucas Garmo; Teck M Soo; Prashant Kelkar; Boyd Richards
Journal:  BMJ Open       Date:  2020-10-05       Impact factor: 2.692
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.